| A G Family Dentistry Llc | |
|
4017 Parliament Dr St B Alexandira LA 71303-3018 | |
| (318) 442-4430 | |
| (318) 442-7705 |
| Full Name | A G Family Dentistry Llc |
|---|---|
| Speciality | Dentist |
| Location | 4017 Parliament Dr St B, Alexandira, Louisiana |
| Authorized Official Name and Position | Anil K Gupta (OWNER) |
| Authorized Official Contact | 3184424430 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| A G Family Dentistry Llc 4017 Parliament Dr St B Alexandira LA 71303-3018 Ph: (318) 442-4430 | A G Family Dentistry Llc 4017 Parliament Dr St B Alexandira LA 71303-3018 Ph: (318) 442-4430 |
| NPI Number | 1558723312 |
|---|---|
| Provider Enumeration Date | 03/22/2016 |
| Last Update Date | 03/22/2016 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558723312 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | 6354 (Louisiana) | Primary |
News Archive
Rusk Rehabilitation at NYU Langone Medical Center (Rusk) will host a series of community events in recognition of National Rehabilitation Awareness Week, September 16-22.
Ten weeks of intensive reading intervention for children with autism spectrum disorder was enough to strengthen the activity of loosely connected areas of their brains that work together to comprehend reading, University of Alabama at Birmingham researchers have found.
The U.S. Food and Drug Administration today warned consumers not to purchase or use a product called "Arrow Brand Medicated Oil & Embrocation," also labeled as "Aceite Medicinal La Flecha (Spanish) or "箭嘜驅風油 (Mandarin)." The product is potentially toxic and contains two substances, methyl salicylate and camphor, which are poisonous when ingested.
A compound developed by Johns Hopkins researchers that blocks glutamine metabolism can slow tumor growth, alter the tumor microenvironment and promote the production of durable and highly active anti-tumor T cells.
Amgen Inc. today announced the publication of results from the first open-label study to compare Nplate® (romiplostim) treatment to standard of care therapies (SOC) in non-splenectomized adult patients with chronic immune thrombocytopenia (ITP). The study results, which were published today in the New England Journal of Medicine (NEJM), show that both the incidence of treatment failure and need for splenectomy were reduced among the Nplate-treated patients.
› Verified 4 days ago